Outlook Therapeutics (OTLK) EPS (Diluted) (2016 - 2026)
Outlook Therapeutics (OTLK) reported EPS (Diluted) of -$0.15 for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$0.55 a year earlier.
Powered by 
Analysis
Outlook Therapeutics (OTLK) EPS (Diluted) (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Outlook Therapeutics' EPS (Diluted) came in at -$0.45; for FY2025 (ended Sep 30, 2025), it came in at -$1.79.
- By fiscal year, EPS (Diluted) came in at -$4.06 in FY2024, -$4.72 in FY2023, -$6.23 in FY2022 and -$6.96 in FY2021.
- Five-year quarterly EPS (Diluted) spans a low of -$8.01 in fiscal Q2 2024 and a high of $1.74 in fiscal Q3 2024.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -$0.05 (Q2 2026), -$0.38 (Q1 2026) and -$0.38 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.94 |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.27 |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.85 |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 4.37 |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -0.04 |
| 10 | Outlook Therapeutics | 80.68 Mn | 44.93 Mn | -8,265.00 | -0.15 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.15 |
| Mar 31, 2026 | -0.05 |
| Dec 31, 2025 | -0.38 |
| Sep 30, 2025 | -0.38 |
| Jun 30, 2025 | -0.55 |
| Mar 31, 2025 | -1.50 |
| Dec 31, 2024 | 0.72 |
| Sep 30, 2024 | 0.31 |
| Jun 30, 2024 | 1.74 |
| Mar 31, 2024 | -8.01 |
| Dec 31, 2023 | -0.86 |
| Sep 30, 2023 | -1.04 |
| Jun 30, 2023 | -1.61 |
| Mar 31, 2023 | -0.52 |
| Dec 31, 2022 | -1.64 |
| Sep 30, 2022 | -1.35 |
| Jun 30, 2022 | -1.59 |
| Mar 31, 2022 | -1.80 |
| Dec 31, 2021 | -1.54 |
| Sep 30, 2021 | -1.76 |
API Access
Outlook Therapeutics EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();